91 related articles for article (PubMed ID: 19925050)
21. Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
Avramis IA; Kwock R; Avramis VI
Anticancer Res; 2001; 21(4A):2281-6. PubMed ID: 11724283
[TBL] [Abstract][Full Text] [Related]
22. The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Gatto S; Scappini B; Pham L; Onida F; Milella M; Ball G; Ricci C; Divoky V; Verstovsek S; Kantarjian HM; Keating MJ; Cortes-Franco JE; Beran M
Haematologica; 2003 Aug; 88(8):853-63. PubMed ID: 12935973
[TBL] [Abstract][Full Text] [Related]
23. Stromal cells attenuate the cytotoxicity of imatinib on Philadelphia chromosome-positive leukemia cells by up-regulating the VE-cadherin/β-catenin signal.
Chen C; Zhang HX; Wang M; Song XG; Cao J; Wang L; Qiao JL; Lu XY; Han ZX; Zhu P; Pan B; Wu QY; Zhao K; Yan ZL; Li ZY; Zeng LY; Xu KL
Leuk Res; 2014 Dec; 38(12):1460-8. PubMed ID: 25443888
[TBL] [Abstract][Full Text] [Related]
24. Synchronization and recruitment in acute leukemia.
Lampkin BC; Nagao T; Mauer AM
J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
[TBL] [Abstract][Full Text] [Related]
25. Combined treatment of 3-hydroxyflavone and imatinib mesylate increases apoptotic cell death of imatinib mesylate-resistant leukemia cells.
Kim JH; Song M; Kang GH; Lee ER; Choi HY; Lee C; Kim JH; Kim Y; Koo BN; Cho SG
Leuk Res; 2012 Sep; 36(9):1157-64. PubMed ID: 22770910
[TBL] [Abstract][Full Text] [Related]
26. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
27. Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.
Jørgensen HG; Allan EK; Graham SM; Godden JL; Richmond L; Elliott MA; Mountford JC; Eaves CJ; Holyoake TL
Leukemia; 2005 Jul; 19(7):1184-91. PubMed ID: 15889158
[TBL] [Abstract][Full Text] [Related]
28. An in vitro study of the cytogenetic and cytotoxic effects of imatinib mesylate, STI571 on murine erythroleukemia GM-86 cells.
Kirk MJ; Fotiadis NA; Majumdar SK
J Chemother; 2006 Feb; 18(1):49-55. PubMed ID: 16572894
[TBL] [Abstract][Full Text] [Related]
29. Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers.
Nørregaard A; Jensen SS; Kolenda J; Aaberg-Jessen C; Christensen KG; Jensen PH; Schrøder HD; Kristensen BW
Neurotox Res; 2012 Jul; 22(1):43-58. PubMed ID: 22203610
[TBL] [Abstract][Full Text] [Related]
30. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
Hongo T; Yamada S; Yajima S; Watanabe C; Fujii Y; Kawasaki H; Yazaki M; Hanada R; Horikoshi Y
Int J Hematol; 1999 Dec; 70(4):268-77. PubMed ID: 10643153
[TBL] [Abstract][Full Text] [Related]
31. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
32. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Williams RT; Sherr CJ
Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
[TBL] [Abstract][Full Text] [Related]
33. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
Burt R; Dey A; Aref S; Aguiar M; Akarca A; Bailey K; Day W; Hooper S; Kirkwood A; Kirschner K; Lee SW; Lo Celso C; Manji J; Mansour MR; Marafioti T; Mitchell RJ; Muirhead RC; Cheuk Yan Ng K; Pospori C; Puccio I; Zuborne-Alapi K; Sahai E; Fielding AK
Blood; 2019 Oct; 134(17):1415-1429. PubMed ID: 31501154
[TBL] [Abstract][Full Text] [Related]
34. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
35. Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals.
Hiraga T; Nakamura H
Int J Cancer; 2009 Jan; 124(1):215-22. PubMed ID: 18814279
[TBL] [Abstract][Full Text] [Related]
36. Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells.
Suyama H; Igishi T; Ueda Y; Shigeoka Y; Kodani M; Morita M; Takeda K; Sumikawa T; Nakazaki H; Matsunami K; Matsumoto S; Shimizu E
Oncol Rep; 2010 Jan; 23(1):217-22. PubMed ID: 19956885
[TBL] [Abstract][Full Text] [Related]
37. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
[TBL] [Abstract][Full Text] [Related]
38. Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate.
Chio-Srichan S; Oudrhiri N; Bennaceur-Griscelli A; Turhan AG; Dumas P; Refregiers M
J Photochem Photobiol B; 2010 May; 99(2):100-4. PubMed ID: 20347325
[TBL] [Abstract][Full Text] [Related]
39. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
Holland JF; Ohnuma T
Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376
[TBL] [Abstract][Full Text] [Related]
40. Interaction of albumin and vincristine with a human lymphoblastic leukemia cell line in vitro.
Jackson DV; Nichols AP; Bender RA
Cancer Biochem Biophys; 1980; 4(3):133-6. PubMed ID: 6934024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]